Thiyagu Pandurangan, PhD

We use the tools of synthetic organic chemistry, medicinal chemistry, and chemical biology, and utilizes computational simulations of small molecule-protein interactions to design potent, selective small molecule with drug-like properties in drug discovery that include but are not limited to: (i) Pre-clinical candidate selection (ii) ADME and PK-driven lead optimization (iii) Hit-to-lead progression